News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kim Helen Susan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Kim Helen Susan (Director) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Granted 15,000 options to buy
@ $76, valued at
$1.1M
|
|
| 09/02/2022 |
4
| Kim Helen Susan (Director) has filed a Form 4 on PROTHENA CORP PUBLIC LTD CO|
Txns:
| Granted 30,000 options to buy
@ $27.57, valued at
$827.1k
|
|
| 09/02/2022 |
3
| Kim Helen Susan (Director) has filed a Form 3 on PROTHENA CORP PUBLIC LTD CO |
| 08/27/2021 |
4
| Kim Helen Susan (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Sold 13,505 shares
@ $30.12, valued at
$406.8k
Sold 558 shares
@ $31.01, valued at
$17.3k
Sold 701 shares
@ $30.7623, valued at
$21.6k
Sold 250 shares
@ $31.442, valued at
$7.9k
|
|
| 08/25/2021 |
4
| Kim Helen Susan (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Sold 505 shares
@ $30.03, valued at
$15.2k
Sold 3 shares
@ $30.04, valued at
$90.1
Sold 9,478 shares
@ $30.0776, valued at
$285.1k
|
|
| 07/06/2021 |
4
| Kim Helen Susan (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Sold 198,759 shares
@ $43.3, valued at
$8.6M
Sold 1,241 shares
@ $46.3061, valued at
$57.5k
|
|
| 05/20/2021 |
4
| Kim Helen Susan (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Granted 14,343 options to buy
@ $47.01, valued at
$674.3k
|
|
| 07/06/2020 |
4
| Kim Helen Susan (Director) has filed a Form 4 on Applied Molecular Transport Inc.|
Txns:
| Exercised 800,000 options to buy
@ $0.02, valued at
$16k
|
|
| 06/15/2020 |
4
| Kim Helen Susan (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $20.47, valued at
$204.7k
|
|
| 06/08/2020 |
4
| Kim Helen Susan (Director) has filed a Form 4 on EXICURE, INC.|
Txns:
| Granted 21,693 options to buy
@ $2.79, valued at
$60.5k
|
|
| 06/04/2020 |
3
| Kim Helen Susan (Director) has filed a Form 3 on Applied Molecular Transport Inc. |
| 06/14/2019 |
4
| Kim Helen Susan (Director) has filed a Form 4 on EXICURE, INC.|
Txns:
| Granted 21,693 options to buy
@ $2.78, valued at
$60.3k
|
|
| 05/17/2019 |
4
| Kim Helen Susan (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $15.22, valued at
$152.2k
|
|
| 06/21/2018 |
4
| Kim Helen Susan (Director) has filed a Form 4 on EXICURE, INC.|
Txns:
| Granted 21,693 options to buy
@ $5.82, valued at
$126.3k
|
|
| 06/01/2018 |
4
| Kim Helen Susan (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 7,500 options to buy
@ $42.09, valued at
$315.7k
|
|
| 03/12/2018 |
4
| Kim Helen Susan (Director) has filed a Form 4 on ASSEMBLY BIOSCIENCES, INC.|
Txns:
| Granted 20,000 options to buy
@ $57.53, valued at
$1.2M
|
|
| 03/12/2018 |
3
| Kim Helen Susan (Director) has filed a Form 3 on ASSEMBLY BIOSCIENCES, INC. |
| 10/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2017 |
4
| Kim Helen Susan (Director) has filed a Form 4 on Max-1 Acquisition Corp|
Txns:
| Granted 49,649 options to buy
@ $0
Granted 24,824 options to buy
@ $0 |
|
| 09/28/2017 |
3
| Kim Helen Susan (Director) has filed a Form 3 on Max-1 Acquisition Corp |
| 09/27/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Sold 3,171 shares
@ $179.6639, valued at
$569.7k
|
|
| 08/14/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 6,251 shares
@ $120.09, valued at
$750.7k
Exercised 3,595 options to buy
@ $53.9, valued at
$193.8k
Exercised 2,656 options to buy
@ $51.43, valued at
$136.6k
|
|
| 08/10/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 11,074 shares
@ $115.02, valued at
$1.3M
Sold 1,700 shares
@ $117.27, valued at
$199.4k
Sold 3,800 shares
@ $118.61, valued at
$450.7k
Sold 18,936 shares
@ $119.94, valued at
$2.3M
Sold 31,165 shares
@ $120.4, valued at
$3.8M
Sold 13,274 shares
@ $121.37, valued at
$1.6M
Exercised 79,949 options to buy
@ $53.9, valued at
$4.3M
|
|
| 08/01/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 15,804 shares
@ $108.75, valued at
$1.7M
Sold 7,448 shares
@ $109.74, valued at
$817.3k
Sold 2,725 shares
@ $110.55, valued at
$301.2k
Sold 672 shares
@ $111.6, valued at
$75k
Exercised 10,099 options to buy
@ $51.43, valued at
$519.4k
Exercised 16,550 options to buy
@ $53.9, valued at
$892k
|
|
| 06/05/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc.|
Txns:
| Sold 2,400 shares
@ $72.45, valued at
$173.9k
Exercised 2,400 options to buy
@ $51.43, valued at
$123.4k
|
|
| 05/03/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc. |
| 04/04/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc. |
| 03/02/2017 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc. |
| 12/27/2016 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc. |
| 12/22/2016 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc. |
| 08/16/2016 |
4
| Kim Helen Susan (EVP, Business Development) has filed a Form 4 on Kite Pharma, Inc. |
| 12/21/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/01/2015 |
4
| Kim Helen Susan (Director) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 40,000 options to buy
@ $3.01, valued at
$120.4k
|
|
| 07/01/2014 |
4
| Kim Helen Susan (Director) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $6.52, valued at
$130.4k
|
|
|
|
|